Drug Pipeline

Dimethyl Fumarate (TECFIDERA™) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04381936 Randomised Evaluation of COVID-19 Therapy Pneumonia Recruiting
NCT07483632 A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF)… Relapsing Forms of Multiple Sclerosis Not Yet Recruiting
Phase 2
NCT04292080 Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy Age-related Macular Degeneration (AMD) Recruiting
Sponsors Running Dimethyl Fumarate (TECFIDERA™) Trials
Assistance Publique - Hôpitaux de Paris (1) University of Oxford (1) Biogen (1)
Disease Areas
Multiple Sclerosis (1)
Get alerts when Dimethyl Fumarate (TECFIDERA™) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free